Gas Analyzer for Collapsed Lung

Overseen By Dan Dodd

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Lung Healing Technologies Inc

Disqualifiers: Hemodynamic instability, Pregnant, Prisoners, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

33 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this study is to assess the clinical feasibility of a novel, reusable, low cost gas analyzer that detects breath in chest drains in order to diagnose and heal air leaks. The investigators have developed prototype gas analyzers that attach to the outlet of any analog chest drain, and can be connected temporarily to the sampling port. They detect breath by measuring CO2, O2, and pressure, in order to supplement the information provided by the bubbles in the water seal.

Eligibility Criteria

This trial is for individuals with a collapsed lung, known medically as pneumothorax. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed information on who can participate.

Inclusion Criteria

I am over 18 years old.

For patients who are unable to sign consent, but meet all of the inclusion criteria and none of the exclusion criteria, a legally appointed representative (LAR) will be allowed to sign consent for that patient

Patients that provide informed consent for the study

Exclusion Criteria

I have unstable blood pressure or heart problems.

Pregnant patients

Prisoners

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo gas analysis to detect pleural air leaks using the novel pleural drain gas analyzer

4 weeks

Regular visits for gas analysis and monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment, including the development of pneumothorax up to 4 weeks after chest tube removal

4 weeks

Long-term follow-up

Participants are monitored for accuracy of air leak detection over a one-year period

1 year

Treatment Details

Trial Overview The study is testing a new gas analyzer device designed to detect air leaks in chest drains used for patients with a collapsed lung. It measures CO2, O2, and pressure levels to help diagnose and monitor healing of air leaks.

Who Is Running the Clinical Trial?

Lung Healing Technologies Inc

Lead Sponsor

Trials

1

Recruited

30+